These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 30913520)

  • 1. Liquid biopsy of HPV DNA in cervical cancer.
    Cheung TH; Yim SF; Yu MY; Worley MJ; Fiascone SJ; Chiu RWK; Lo KWK; Siu NSS; Wong MCS; Yeung ACM; Wong RRY; Chen ZG; Elias KM; Chung TKH; Berkowitz RS; Wong YF; Chan PKS
    J Clin Virol; 2019 May; 114():32-36. PubMed ID: 30913520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker.
    Rungkamoltip P; Temisak S; Piboonprai K; Japrung D; Thangsunan P; Chanpanitkitchot S; Chaowawanit W; Chandeying N; Tangjitgamol S; Iempridee T
    Exp Biol Med (Maywood); 2021 Mar; 246(6):654-666. PubMed ID: 33307803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sampling origin on molecular detection of high-risk human papillomavirus and oncogene expression.
    Kahla S; Achour M; Oueslati S; Kochbati L; Chanoufi MB; Maalej M; Oueslati R
    Eur J Gynaecol Oncol; 2012; 33(2):187-92. PubMed ID: 22611961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
    Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
    Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus types 16 and 18 mRNA levels and not DNA levels may be associated with advancing stages of cervical cancer.
    Gnanamony M; Peedicayil A; Subhashini J; Ram TS; Christopher S; Gravitt P; Abraham P
    Int J Gynecol Cancer; 2009 Nov; 19(8):1415-20. PubMed ID: 20009900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.
    Galati L; Combes JD; Le Calvez-Kelm F; McKay-Chopin S; Forey N; Ratel M; McKay J; Waterboer T; Schroeder L; Clifford G; Tommasino M; Gheit T
    Microbiol Spectr; 2022 Apr; 10(2):e0148021. PubMed ID: 35225653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.
    Winer RL; Harris TG; Xi LF; Jansen KU; Hughes JP; Feng Q; Welebob C; Ho J; Lee SK; Carter JJ; Galloway DA; Kiviat NB; Koutsky LA
    J Med Virol; 2009 Apr; 81(4):713-21. PubMed ID: 19235870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
    J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
    [No Abstract]   [Full Text] [Related]  

  • 9. Negative Roche cobas HPV testing in cases of biopsy-proven invasive cervical carcinoma, compared with Hybrid Capture 2 and liquid-based cytology.
    Vasilyeva D; Tiscornia-Wasserman P; Gonzalez AA
    J Am Soc Cytopathol; 2021; 10(2):128-134. PubMed ID: 32896510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and Application of a Method for High-Risk Human Papillomavirus Genotyping in Cervical Cancer Tissue.
    Zou R; Xie W; Wang H; Wang J; Xiao L; Ji S; Chen X; Zhang L; Xue X; Chen J
    Clin Lab; 2016; 62(6):1075-85. PubMed ID: 27468570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
    Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
    Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma.
    Dong SM; Pai SI; Rha SH; Hildesheim A; Kurman RJ; Schwartz PE; Mortel R; McGowan L; Greenberg MD; Barnes WA; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):3-6. PubMed ID: 11815394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
    Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
    Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
    Combes JD; Pawlita M; Waterboer T; Hammouda D; Rajkumar T; Vanhems P; Snijders P; Herrero R; Franceschi S; Clifford G
    Int J Cancer; 2014 Nov; 135(10):2453-61. PubMed ID: 24729277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phylogeny and Classification of Human Papillomavirus (HPV)16 and HPV18 Variants Based on E6 and L1 genes in Tunisian Women with Cervical Lesions.
    Jendoubi-Ferchichi M; Satouri L; Ghoul F; Malek-Mellouli M; Derbel AM; Makni MK; Reziga H; Baba A; Zili M; Segondy M; Khelifa R
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3361-3366. PubMed ID: 30583341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
    Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
    PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of HPV16 and 18 by in situ hybridization in precancerous and cancerous lesions of cervix.
    Choudhury M; Singh S
    Indian J Pathol Microbiol; 2006 Jul; 49(3):345-7. PubMed ID: 17001881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
    Rosales R; López-Contreras M; Cortes RR
    J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.